Previous 10 | Next 10 |
Summary Global growth stocks held up better than value, snapping a two-quarter losing streak, as global recession fears weighed more heavily on companies tied to the broader economy. The Strategy outperformed for the second quarter in a row, thanks in large part to positioning adj...
Summary Having suffered through a sharp decline in earnings multiples, SMID cap growth stocks held up well in a volatile quarter marked by a sharp upward ratcheting of interest rates. The Strategy underperformed its benchmark, primarily due to weakness among health care holdings t...
Summary Against a background of rising rates and recession risks, the Strategy outperformed its benchmark driven by our selections in the IT, industrials and health care sectors. We were active in repositioning the portfolio in the quarter as market crosswinds opened idiosyncratic...
Summary While U.S. utilities dominated top contributors in the quarter, utilities in Europe suffered from growing fear of sector intervention amid several economic and political uncertainties. The U.S. Inflation Reduction Act was announced in August and has become a major tailwind...
Summary The third quarter was dominated by central banks’ efforts to fight inflation through tightening monetary policy; as the Fed and other central banks continued to raise rates, bond yields rose across the globe. The U.S. Inflation Reduction Act was announced in August ...
Summary Several long-standing biopharmaceutical holdings drove performance. An unprecedented set of global challenges makes it more important than ever to own cash-generative businesses with strong balance sheets that can take advantage of dislocations in the market and the econom...
Summary Even with oil prices lower in the quarter, energy prices remain stubbornly high and will likely remain in a tight supply and demand balance even if economies slow down meaningfully. This backdrop will continue to support the pipelines over the medium term as energy produce...
Summary A rebound for several disruptors in the consumer discretionary sector offset weakness in health care, enabling the Strategy to outperform through a short-lived rally and subsequent drawdown. We initiated two new positions in rapidly growing disruptors whose valuations have...
Summary Markets declined during the third quarter as investors became convinced that monetary authorities would drive global economies into recession. The Strategy outperformed its benchmark due to its tilt towards “real economy” cyclical sectors, rather than defensi...
Summary International markets faced headwinds as slowing economic growth and hawkish monetary policy by central banks stoked investor fears of a possible global recession. The Strategy outperformed its benchmark, as high-quality stocks in the materials and industrials sectors over...
News, Short Squeeze, Breakout and More Instantly...
ClearBridge Energy Midstream Opportunity Fund Inc. Company Name:
EMO Stock Symbol:
NYSE Market:
ClearBridge Energy Midstream Opportunity Fund Inc. (NYSE: EMO) announced today the unaudited statement of assets and liabilities, the net asset value and asset coverage ratio of the Fund as of June 30, 2024. As of June 30, 2024, the Fund’s net assets were $292.0 million, and its net as...
ClearBridge Energy Midstream Opportunity Fund Inc. (NYSE: EMO) (the “Fund”) announced today the final results for its issuer tender offer for up to 50% of the outstanding shares of common stock (“Shares”) of the Fund (the “Tender Offer”). The Tender Offer...
ClearBridge MLP and Midstream Fund Inc. (NYSE: CEM) (the “Fund”) announced today the final results for its issuer tender offer for up to 50% of the outstanding shares of common stock (“Shares”) of the Fund (the “Tender Offer”). The Tender Offer expired on...